Hyperthyroid Heart Disease With Some Comorbidities

##plugins.themes.academic_pro.article.main##

Abdi Dzul Ikram Hasanuddin
Sandra Dunggio
Hannan Zubaidi

Abstract

Thyroid disease is quite common. The cardiovascular clinical manifestations of hyperthyroidism are palpitation, systolic hypertension, fatigue, or with the basis of existing heart disease, angina or heart failure. In men, the disease is more frequently to develop into congestive heart failure than in women, thus more exploration is needed. This case report discussed a 42-year-old male patient who was admitted to the emergency department due to palpitations, shortness of breath aggravated with activity and lie down position, and alleviated with resting, cough with white sputum, epigastric pain, and constipation since the past 3 days. He was diagnosed with a history of hyperthyroidism and congestive heart disease 1 year ago and routinely consumed propylthiouracil (PTU). He had a history of herniotomy 10 days before admission. The patient did not have a history of hypertension, diabetes mellitus, or hypercholesterolemia. The patient has a smoking habit of up to 3 packs/day since a teenager. The patient was diagnosed with hyperthyroid heart disease (congestive heart failure, atrial fibrillation, and coronary heart disease) with comorbid of electrolyte imbalance, hypoalbuminemia, and thrombocytopenia. The patient was treated in the Intensive Care Unit (ICU) and was given oxygen therapy, crystalloid infusion, antithyroid drug, beta-blocker, diuretics, digitalis, anti-angina, anti-thrombotic, and adjunct therapy. The patient was treated for 8 days in ICU, followed by 2 days in the ward with a good outcome. Early detection and intervention followed by close monitoring is key management for the patient with hyperthyroid heart disease, especially in a male patient, to achieve a better outcome.

##plugins.themes.academic_pro.article.details##

References

1. Klein, I. & Danzi, S. Cardiovascular Involvement in General Medical Conditions
Thyroid Disease and the Heart. (2015). doi:10.1161/CIRCULATIONAHA.106.678326
2. Siu, C., Yeung, C., Lau, C., Kung, A. W. C. & Tse, H. Incidence, clinical characteristics
and outcome of congestive heart failure as the initial presentation in patients with
primary hyperthyroidism. 483–487 (2007). doi:10.1136/hrt.2006.100628
3. D, A. & Y, K. Thyroid Heart Disease. in Textbook on Internal Medicine Volume II (eds.
AW, S., B, S. & Alwi) 1798–1803 (Interna Publishing, 2009).
4. MM, P. Hypertention Heart Disease. in Internal medicine textbook (eds. AW, S., C, S. &
Alwi) 1693 (Center for Publishing the Department of Internal Medicine FK UI, 2006).
5. DS, C., FS, G. & PW, L. The Thyroid Gland. in Greenspan‟s Basic & Clinical
Endocrinology (eds. DG, G. & D, S.) (: The McGraw-Hill Companies, Inc, 2007).
6. BB, S., S, D., DA, J. & R, S. Guidelines for the management of cardiovascular disease
in Indonesia. (Indonesian Association of Cardiovascular Specialists, 2009).
7. Chaudhry, L. ali, Mazen, K. F., Ba-Essa, E. & Robert, A. A. Case report Antithyroid
drug induced agranulocytosis : what still we need to learn ? 8688, 1–6 (2016).
8. Rizos, C. V, Elisaf, M. S. & Liberopoulos, E. N. Effects of Thyroid Dysfunction on
Lipid Profile. 76–84 (2011).
9. Goldman, S. Thyroid and Cardiovascular Disease. 2892–2909 (2019). doi:10.1161/CIRCULATIONAHA.118.036859
10. Sklyar, E. et al. World Journal of Cardiology. 9, 248–254 (2017).
11. A, G. Introduction to the diagnosis of echocardiography. (Department of Internal
Medicine Science FKUI, 2009).
12. TF, D. Thyrotoxicosis. in (ed. HM, K.) (William Textbook of Endocrinology, 2008).
13. A, S. & Nafrialdi. Medication for Heart Failure. (Department of Pharmacology and
Therapeutic FKUI, 2007).
14. A, J. & LD, L. Antioxidants and coronary artery disease: from athophysiology to
preventive therapy. Coron Artery Dis 26, 176–183 (2016).
15. Ishiyama, Y., Hoshide, S., Mizuno, H. & Kario, K. Constipation ‐ induced pressor
effects as triggers for cardiovascular events. J Clin Hpertens 1–5 (2019).
doi:10.1111/jch.13489